Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myomo (MYO) Asset Writedowns and Impairment (2017 - 2025)

Myomo filings provide 8 years of Asset Writedowns and Impairment readings, the most recent being $103779.0 for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $103779.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $193822.0, a 821.56% increase, with the full-year FY2024 number at $43657.0, up 53.72% from a year prior.
  • Asset Writedowns and Impairment hit $103779.0 in Q3 2025 for Myomo, up from $51643.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $103779.0 in Q3 2025 to a low of -$374.0 in Q3 2023.
  • Median Asset Writedowns and Impairment over the past 4 years was $20925.0 (2022), compared with a mean of $31694.4.
  • Biggest five-year swings in Asset Writedowns and Impairment: plummeted 50.14% in 2023 and later surged 143.42% in 2024.
  • Myomo's Asset Writedowns and Impairment stood at $26075.0 in 2022, then tumbled by 39.5% to $15775.0 in 2023, then surged by 143.42% to $38400.0 in 2024, then skyrocketed by 170.26% to $103779.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $103779.0 (Q3 2025), $51643.0 (Q1 2025), and $38400.0 (Q4 2024) per Business Quant data.